<SEC-DOCUMENT>0001493152-25-003386.txt : 20250123
<SEC-HEADER>0001493152-25-003386.hdr.sgml : 20250123
<ACCEPTANCE-DATETIME>20250123161035
ACCESSION NUMBER:		0001493152-25-003386
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250123
DATE AS OF CHANGE:		20250123

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RANGE IMPACT, INC.
		CENTRAL INDEX KEY:			0001438943
		STANDARD INDUSTRIAL CLASSIFICATION:	HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				753268988
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-84210
		FILM NUMBER:		25550200

	BUSINESS ADDRESS:	
		STREET 1:		200 PARK AVENUE
		STREET 2:		SUITE 400
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44122
		BUSINESS PHONE:		530-231-7800

	MAIL ADDRESS:	
		STREET 1:		200 PARK AVENUE
		STREET 2:		SUITE 400
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MALACHITE INNOVATIONS, INC.
		DATE OF NAME CHANGE:	20211012

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vitality Biopharma, Inc.
		DATE OF NAME CHANGE:	20160721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stevia First Corp.
		DATE OF NAME CHANGE:	20111020

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LoConti Joseph E.
		CENTRAL INDEX KEY:			0001025708
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		6140 PARKLAND BLVD.
		CITY:			MAYFIELD HEIGHTS
		STATE:			OH
		ZIP:			44124

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LOCONTI JOSEPH E
		DATE OF NAME CHANGE:	19961022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0001193125-18-315961</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: LoConti Joseph E. -->
          <cik>0001025708</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>COMMON STOCK</securitiesClassTitle>
      <dateOfEvent>01/21/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001438943</issuerCIK>
        <issuerCUSIP>92849B107</issuerCUSIP>
        <issuerName>Range Impact, Inc.</issuerName>
        <address>
          <com:street1>200 Park Avenue, Suite 400</com:street1>
          <com:city>Orange Village</com:city>
          <com:stateOrCountry>OH</com:stateOrCountry>
          <com:zipCode>44122</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Howard Groedel,</personName>
          <personPhoneNum>216.583.7000</personPhoneNum>
          <personAddress>
            <com:street1>1660 West 2nd Street, Suite 1100,</com:street1>
            <com:city>Cleveland</com:city>
            <com:stateOrCountry>OH</com:stateOrCountry>
            <com:zipCode>44113</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001025708</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Joseph E. LoConti</reportingPersonName>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>7387310.00</soleVotingPower>
        <sharedVotingPower>16797146.00</sharedVotingPower>
        <soleDispositivePower>7387310.00</soleDispositivePower>
        <sharedDispositivePower>16797146.00</sharedDispositivePower>
        <aggregateAmountOwned>24184456.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>22.4</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>COMMON STOCK</securityTitle>
        <issuerName>Range Impact, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>200 Park Avenue, Suite 400</com:street1>
          <com:city>Orange Village</com:city>
          <com:stateOrCountry>OH</com:stateOrCountry>
          <com:zipCode>44122</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment ("Amendment") amends the Reporting Person's initial Schedule 13D filed on November 1, 2018, as amended on February 7, 2019, April 2, 2019, and May 27, 2022 (collectively, the "Schedule 13D") with respect to the shares of the Common Stock, par value $0.001 per share ("Common Stock"), of Range Impact, Inc. (the "Company"). Capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D. The purpose of this Amendment is to report a change in the number of shares of the Common Stock of the Company beneficially owned by the Reporting Person.</commentText>
      </item1>
      <item3>
        <fundsSource>The additional shares of Common Stock that were purchased by the Reporting Person set forth below in this Amendment were acquired by Tower IV LLC, an Ohio limited liability company ("Tower IV"), in a privately-negotiated transaction with the Company pursuant to a Securities Purchase Agreement between the Company and Tower IV, dated as of January 21, 2025, in exchange for $500,000. The funds used in making this purchase came from Tower IV's working capital. Mr. LoConti is the sole manager of Tower IV.</fundsSource>
      </item3>
      <item5>
        <percentageOfClassSecurities>The information in Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a) Mr. LoConti has the sole power to vote and dispose of 7,387,310 shares of the Common Stock of the Company representing approximately 6.8% of the total number of shares of Common Stock of the Company outstanding as of the date of this Amendment.

(b) Mr. LoConti and Tower IV have the shared power to vote and dispose of 16,797,146 shares of the Common Stock of the Company, representing approximately 15.5% of the total number of shares of Common Stock of the Company outstanding as of the date of this Amendment.

(c) Tower IV acquired 3,333,333 shares of Common Stock of the Company in a privately-negotiated transaction pursuant to a Securities Purchase Agreement entered into between Tower IV and the Company, dated January 21, 2025. The consideration paid by Tower IV for the shares of Common Stock acquired pursuant to the Securities Purchase Agreement was $500,000, or $0.15 per share of Common Stock acquired.

(d) No other person is known by the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock of the Company beneficially owned by the Reporting Person.

(e) Not applicable.</percentageOfClassSecurities>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Joseph E. LoConti</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Joseph E. LoConti</signature>
          <title>Joseph E. LoConti</title>
          <date>01/23/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
